Oral beclomethasone dipropionate therapy and prognostic plasma biomarkers for gastrointestinal graft-versus-host disease.

Saved in:
Bibliographic Details
Title: Oral beclomethasone dipropionate therapy and prognostic plasma biomarkers for gastrointestinal graft-versus-host disease.
Authors: Inamoto Y; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan. yinamoto@fujita-hu.ac.jp.; Department of Blood and Marrow Transplantation and Cellular Therapy, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan. yinamoto@fujita-hu.ac.jp., Ito A; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Nakashima T; Division of Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Usui A; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Takeda W; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Tanaka T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Kim SW; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Kitano S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Advanced Medical Development, The Cancer Institute Hospital of JFCR, Tokyo, Japan., Watanabe K; Division of Cancer Immunology, Research Institute, National Cancer Center, Tokyo, Japan., Kusaba K; Division of Cancer Immunology, Research Institute, National Cancer Center, Tokyo, Japan.; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan., Aruga Y; Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology and Translational Research, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan., Ikeda C; Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo, Japan., Kojima M; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Maezawa N; Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo, Japan., Matsui H; Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology and Translational Research, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan., Hashimoto H; Division of Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Ogawa C; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan., Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Source: International journal of hematology [Int J Hematol] 2025 Aug; Vol. 122 (2), pp. 257-266. Date of Electronic Publication: 2025 Mar 25.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1865-3774
DOI:10.1007/s12185-025-03973-7